Canine Diabetes Mellitus: Long-Term Clinical Management

Bottom line

Manage the dog, the insulin response and the home delivery process together. AAHA prioritizes control of polyuria, polydipsia and polyphagia, appropriate body weight, and avoidance of hypoglycemia over tight glucose normalization. [1] A useful long-term plan explains what will trigger reassessment and who will interpret the next monitoring record.

Start each recheck with a clinical question

AAHA recommends a blood glucose curve or CGM when evaluating uncontrolled diabetes; isolated spot values should not be the sole reason to increase insulin. Persistent signs can reflect inadequate duration of insulin action or another disease, and a larger dose may create hypoglycemia. [1]

Write down the decision before ordering the test. Are signs persisting throughout the day, recurring near the end of an injection interval, or appearing after an earlier period of acceptable control? Record weight trajectory, actual intake, urinary habits, activity, and the timing of insulin and meals. Preserve the caregiver's account alongside the device export so discrepancies remain visible.

A previously stable dog that becomes systemically ill needs a new assessment rather than automatic outpatient titration. The canine DKA inpatient pathway addresses the separate ketone, acid-base and stabilization decisions when a metabolic crisis is suspected.

Check what insulin actually reaches the patient

AAHA's troubleshooting sequence begins with observing storage, mixing, the syringe used and administration. It also reviews diet, potentially insulin-antagonistic medications and concurrent disease before escalating therapy. [2]

Ask the caregiver to demonstrate the complete process with the product and equipment in use. Reconcile the written prescription, what the household understands, and what was administered. Record who gives injections and how missed, partial or uncertain administrations are reported. A signed instruction sheet is not evidence that delivery has been demonstrated successfully.

Document changes in food, treats and household routine. Make one coherent plan available to every caregiver and establish a way to report problems without independent dose experimentation. If a product or administration method changes, update the entire record rather than leaving several conflicting instructions active.

Interpret CGM trends with confirmation and context

AAHA describes CGM as a way to examine home interstitial glucose trends across meals, exercise and other events. It recommends confirming low FreeStyle Libre readings with a veterinary-calibrated portable blood glucose meter before altering therapy, particularly when the dog has no hypoglycemic signs. [3]

Specify what the caregiver should record with an unexpected value and how the clinical team will respond. Do not let an asymptomatic sensor discrepancy become an automatic titration instruction. Conversely, a dog with concerning clinical signs needs prompt clinical assessment rather than waiting for a more reassuring graph.

Corradini and colleagues prospectively evaluated a flash system in ten insulin-treated diabetic dogs without concurrent disease. Clinical accuracy was lower in the hypoglycemic range. A single sensor was used per dog, so between-sensor precision was not investigated; the authors called for further work on long-term use and hypoglycemia detection. [4]

This is device-specific validation evidence, not proof of improved survival, freedom from hypoglycemia, or identical performance across subsequent sensor generations and critically ill populations. Distinguish validation of a measurement from validation of a treatment decision made from that measurement.

Investigate a changed response before cycling through doses

AAHA identifies medication exposure, infection, dental disease, endocrine disorders and pancreatitis among contributors to poor control. Pancreatic inflammation can produce changing insulin requirements; increasing doses during inflammation can create hypoglycemia as resistance resolves. The guideline recommends specialist consultation when regulation remains unsuccessful. [2]

The canine acute pancreatitis management reference covers the independent diagnostic and supportive-care questions when that comorbidity is suspected. Avoid assigning pancreatitis from a diabetic dog's glucose pattern alone.

At the end of the visit, state the working explanation for loss of control, the evidence still missing, the next monitoring method and the clinician responsible for review. Keep safety instructions separate from routine follow-up. Reconcile urgent illness contacts, data submission and planned reassessment so the home plan remains usable between appointments.

Frequently Asked Questions

What is the primary goal when treating a stable diabetic dog?

Control clinical signs, maintain appropriate body weight and avoid hypoglycemia; AAHA does not prioritize tight glucose normalization. [1]

Is an isolated high glucose value enough to increase insulin?

No. AAHA advises interpreting the insulin response with a curve or CGM and the clinical picture. [1]

Why can increasing the dose be the wrong response to persistent signs?

Short insulin duration or another disease may explain the signs; increasing the dose can cause hypoglycemia. [1]

What should be checked before labeling a dog insulin resistant?

Observe storage, mixing, syringe selection and injection technique, and review diet, medication exposure and concurrent disease. [2]

Should an unexpected low Libre value in an asymptomatic dog automatically change treatment?

AAHA recommends confirmation with a veterinary-calibrated portable blood glucose meter before altering therapy. [3]

Does the early Libre study validate every current sensor in every ill dog?

No. It studied ten insulin-treated diabetic dogs without concurrent disease, using the device evaluated at that time. [4]

Did that study show equally strong accuracy across glucose ranges?

No. Clinical accuracy was lower in the hypoglycemic range, and the authors requested further evaluation of hypoglycemia detection. [4]